Dianthus Therapeutics (DNTH) PT Raised to $100 at Guggenheim
Tweet Send to a Friend
Guggenheim analyst Yatin Suneja raised the price target on Dianthus Therapeutics (NASDAQ: DNTH) to $100.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
